Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
56.9M
-
Number of holders
-
138
-
Total 13F shares, excl. options
-
25.9M
-
Shares change
-
+2.15M
-
Total reported value, excl. options
-
$977M
-
Value change
-
+$93.8M
-
Put/Call ratio
-
0
-
Number of buys
-
106
-
Number of sells
-
-36
-
Price
-
$37.74
Significant Holders of GLAUKOS Corp - Common Stock (GKOS) as of Q3 2016
156 filings reported holding GKOS - GLAUKOS Corp - Common Stock as of Q3 2016.
GLAUKOS Corp - Common Stock (GKOS) has 138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.9M shares
of 56.9M outstanding shares and own 45.49% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2.18M shares), Meritech Capital Associates III L.L.C. (2.1M shares), LORD, ABBETT & CO. LLC (1.81M shares), Capital World Investors (1.71M shares), GILDER GAGNON HOWE & CO LLC (1.61M shares), VANGUARD GROUP INC (1.15M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.08M shares), FEDERATED INVESTORS INC /PA/ (983K shares), NEXT CENTURY GROWTH INVESTORS LLC (861K shares), and ALLIANCEBERNSTEIN L.P. (788K shares).
This table shows the top 138 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.